Skip to Content

KPI 116 (Cytomel 25 mcg (0.025 mg))

Generic Name: liothyronine

Pill imprint KPI 116 has been identified as Cytomel 25 mcg (0.025 mg).

Cytomel is used in the treatment of hypothyroidism, after thyroid removal; tsh suppression; myxedema; thyroid suppression test; underactive thyroid (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Cytomel 25 mcg (0.025 mg) is not subject to the Controlled Substances Act.

See also related documents.

Cytomel 25 mcg (0.025 mg) KPI 116
Cytomel 25 mcg (0.025 mg) KPI 116  Front
Cytomel 25 mcg (0.025 mg) KPI 116  Back
Generic Name:
KPI 116
25 mcg (0.025 mg)
White / White
7.00 mm
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
N - Not a controlled drug
King Pharmaceuticals Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-2053 A-S Medication Solutions, LLC (repackager)
54868-1750 Physicians Total Care Inc (repackager)
68258-9017 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.